Home
Conditions
Influenza

Clinical trial condition

Influenza

Explore clinical trials studying Influenza. Study availability and eligibility vary by location and protocol.

1,207 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Influenza trial results

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine

NCT01265914

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Hammersmith Medicines Research Ltd London, United Kingdom

View Trial Details

Completed

Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza

NCT00192413

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Docnor House Durban North, Dwazulu Natal, South Africa

Hazelmed Family Practice Hazelwood, Pretoria, South Africa

Jansen van Rensburg eManzimtoti, South Africa

Christiaan Tertius de Villiers Scottburgh South, South Africa

View Trial Details

Completed

A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.

NCT00192179

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Catholic University Leuven Leuven, Belgium

Zamenhoflaan 12 Schoten, Belgium

Universiteit Antwerpen Wilrijk, Belgium

Oddzial Dzieciecy Szpitala Powiatowete im Trzebnica, Poland

View Trial Details

Completed

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children

NCT00192322

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Suncoast Clinical Research, Inc. New Port Richey, Florida, United States

Division of Allergy Immunology and Infectious Disease Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.

NCT00192309

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: David M. Radin, MD Stamford, Connecticut, United States

View Trial Details

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects

NCT00522236

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Dipartimento di Medicina e Scienze dell'Invecchiamento Chieti, Italy

Ufficio Igiene e Sanità Pubblica di Lanciano, ASL Lanciano - Vasto, Via S. Spaventa, 37 Lanciano, Italy

View Trial Details

Completed

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders

NCT01003145

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: National Taiwan University Hospital Taipei, Taiwan

Taipei Medical University Wang Fang Hospital Taipei, Taiwan

Tri-Service General Hospital Taipei, Taiwan

View Trial Details

Completed

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population

NCT01007201

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: National Taiwan University Hospital Taipei, Taiwan

Chang Gung Memorial Hospital Taoyuan Hsien, Taiwan

View Trial Details

Completed

Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults

NCT00819013

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Miami Research Associates Miami, Florida, United States

Johnson County Clin-Trials Lenexa, Kansas, United States

Northwest Kinetics Tacoma, Washington, United States

View Trial Details

Completed

Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects

NCT01313962

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Quintiles Phase One Services Overland Park, Kansas, United States

View Trial Details

Influenza

Influenza trial results

Related conditions